Medicine Man Technologies Inc (SHWZ) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Medicine Man Technologies Inc stock forecast from 0 analysts, the average analyst target price for Medicine Man Technologies Inc is not available over the next 12 months. Medicine Man Technologies Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Medicine Man Technologies Inc is Slightly Bearish, which is based on 5 positive signals and 7 negative signals. At the last closing, Medicine Man Technologies Inc’s stock price was USD 0.02. Medicine Man Technologies Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -96.10% over the last year.
No recent analyst target price found for Medicine Man Technologies Inc
No recent average analyst rating found for Medicine Man Technologies Inc
Company Overview Medicine Man Technologies Inc
Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. It operates through Retail, Wholesale, and Others segments. The company offers loose flower, concentrates, edibles, pre-rolls, topicals, infused beverages, and other associated cannabis products produced by cannabis vendors; and cannabis and non-cannabis products. It operates retail cannabis dispensaries under the Star Buds, Emerald Fields, Standing Akimbo, Everest Cannabis Co., and R. Greenleaf brand names. In addition, the company sells indoor gardening supplies and hydroponics through its online and retail store. Medicine Man Technologies, Inc. was incorporated in 2014 and is headquartered in Denver, Colorado. Read Less
Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. It operates through Retail, Wholesale, and Others segments. The company offe...Read More
Frequently Asked Questions About Medicine Man Technologies Inc (SHWZ) Stock
Stock Target Advisor's fundamental analysis for Medicine Man Technologies Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on SHWZ's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on SHWZ's stock to indicate what its average analyst target is.
SHWZ stock's Price/Earning ratio is 14.59.
Our analysis grades SHWZ stock's Price / Earning ratio at A+. This means that SHWZ stock's Price/Earning ratio is above 0% of the stocks in the Pharmaceutical Retailers sector in the OTC exchange.
Based on this SHWZ may be undervalued for its sector.
The last closing price of SHWZ's stock was USD 0.02.
The most recent market capitalization for SHWZ is USD 1.60M.
Unfortunately we do not have enough analyst data on SHWZ's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Medicine Man Technologies Inc's stock.
As per our most recent records Medicine Man Technologies Inc has 729 Employees.
Medicine Man Technologies Inc's registered address is 865 North Albion Street, Denver, CO, United States, 80220.
You can get more information about it from Medicine Man Technologies Inc's website at https://www.schwazze.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Medicine Man Technologies Inc (SHWZ) Stock
Stock Target Advisor's fundamental analysis for Medicine Man Technologies Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on SHWZ's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on SHWZ's stock to indicate what its average analyst target is.
SHWZ stock's Price/Earning ratio is 14.59.
Our analysis grades SHWZ stock's Price / Earning ratio at A+. This means that SHWZ stock's Price/Earning ratio is above 0% of the stocks in the Pharmaceutical Retailers sector in the OTC exchange.
Based on this SHWZ may be undervalued for its sector.
The last closing price of SHWZ's stock was USD 0.02.
The most recent market capitalization for SHWZ is USD 1.60M.
Unfortunately we do not have enough analyst data on SHWZ's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Medicine Man Technologies Inc's stock.
As per our most recent records Medicine Man Technologies Inc has 729 Employees.
Medicine Man Technologies Inc's registered address is 865 North Albion Street, Denver, CO, United States, 80220.
You can get more information about it from Medicine Man Technologies Inc's website at https://www.schwazze.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SHWZ !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
